{
    "code": "10000856",
    "time": "2015-06-24 14:57:42",
    "許可證字號": "衛署菌疫輸字第000856號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/03\/27",
    "發證日期": "97\/03\/27",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000085606",
    "中文品名": "保蓓TM人類乳突病毒第16\/18型疫苗",
    "英文品名": "Cervarix TM Human Papillomavirus vaccine Type 16 and 18 (Recombinant, AS04 adjuvanted)",
    "適應症": "適用於9歲至25歲的女性，藉以預防致癌性人類乳突病毒(HPV)第16型、第18型所引起的持續性感染、子宮頸癌前病變，及子宮頸癌",
    "劑型": "275懸浮注射劑",
    "包裝": "單劑量0.5ml預充填型注射器附針頭 單劑量0.5ml小瓶裝 1支、10支、100支盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN",
    "限制項目": [
        "02輸入",
        "1EPhaseIVStudy"
    ],
    "申請商名稱": "6201011338  荷商葛蘭素史克藥廠股份有限公司台灣分公司",
    "申請商地址": "臺北市松山區民生東路３段１５６號８樓之１之２之３之５及之６",
    "主製造廠": {
        "製造廠名稱": "F050018000  GLAXOSMITHKLINE BIOLOGICALS S.A.",
        "製造廠廠址": "89 RUE DE L'INSTITUT 1330 RIXENSART-BELGIUM",
        "製造廠公司地址": "",
        "製造廠國別": "BELGIUM",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "8012007000",
            "成分名稱": "HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "UG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "8012007100",
            "成分名稱": "HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "UG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 020008560001-104-02-17.pdf 020008560004___20100610.jpg 020008560003___20100610.jpg 020008560002___20120903.pdf 020008560002___20100610.jpg 020008560001___20120903.pdf 020008560001___20100610.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000856&Seq=007&Type=9"
        }
    ]
}